We describe a patient with multiply recurrent melanoma harboring an EZH2 A692V missense mutation—a pathogenic variant most commonly described in follicular lymphoma—who experienced a prolonged relapse-free survival with adjuvant tazemetostat. The gene discussed is EZH2; the disease is melanoma.